Electroporation Therapy Systems, Tissue Ablation

Definition : Electroporation therapy systems designed to induce the death of tissue cells by applying an electric field that causes permanent permeability of the cell membrane (i.e., irreversible electroporation) with negligible thermal effects. These systems typically include an electric generator capable of delivering appropriate short-term (e.g., microsecond) electrical pulses with a voltage high enough to cause permanent perforation of the cell walls,; a computerized unit with a display to control and monitor the delivery of electric energy;, and a set of detachable probes with very thin needle electrodes at the distal end that are inserted around the tissue to be ablated. Irreversible electroporation tissue ablation affects only well-defined areas without extending its effects to surrounding tissue, sparing large blood vessel scaffolds and other (e.g., bile) ducts. Tissue ablation irreversible electroporation therapy systems are intended for ablation of abnormal cells; they may be also used for treatment of tumors in difficult to access areas of the body and/or near large blood vessels.

Entry Terms : "Nano Knives" , "Irreversible Electroporation Therapy Systems" , "Electroporation Surgical Units" , "Tissue Ablation Systems"

UMDC code : 26793

U.S.companies only
Suppress Subsidiary Companies

1-2 of 2 Match(es).

AngioDynamics Inc

Company Type: Parent

Founded in 1988 in Queensbury, N.Y., U.S., AngioDynamics is today a NASDAQ-listed public company. We are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. Our diverse product line includes market-leading radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products.

Bio-Rad Laboratories Inc

Company Type: Parent

Bio-Rad Laboratories continues to play a leading role in the advancement of scientific discovery by offering a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 7,000 employees and serves more than 100,000 research and industry customers worldwide through the company's global network of operations.

1-2 of 2 Match(es).


Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone